RSS

blood cancer

Clinical-stage biopharmaceutical company, Autolus has announced the publication of an article detailing a unique targeting strategy for the treatment of patients with T-cell lymphomas in Nature Medicine. more

News

Kiadis Pharma, a clinical stage biopharmaceutical company, has submitted a marketing authorisation application (MAA) to the EMA for its lead product ATIR101 more

News

The European Commission has approved Jakavi (ruxolitinib) from Novartis for the treatment of adult patients with polycythemia vera (PV) who are resistant to or intolerant of hydroxyurea. more

News

Zydelig is being granted traditional approval to treat patients whose chronic lymphocytic leukemia (CLL) has returned (relapsed). more